Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Retirement Articles

Why I feel buying the AstraZeneca share price could destroy your retirement riches

| Roland Head

Roland Head explains why he's avoiding AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

Worried about your State Pension income? Here are 2 FTSE 100 dividend stocks I’d buy today

| Peter Stephens

These two FTSE 100 (INDEXFTSE:UKX) stocks could deliver improving income returns in my opinion.

Read more »

Investing Articles

Investing your first £2K? I’d buy these 2 FTSE 100 shares today

| Kevin Godbold

These two defensive FTSE 100 (INDEXFTSE: UKX) companies have decent dividend yields and growth potential.

Read more »

Investing Articles

What I think will happen to the AstraZeneca share price

| Andy Ross

The AstraZeneca plc (LON: AZN) share price has been going up and up, and here's what I think will happen…

Read more »

Investing Articles

The AstraZeneca share price continues to soar. Time to buy?

| Alan Oscroft

The AstraZeneca plc (LON: AZN) share price is up 45% in five years, and here's why I think it has…

Read more »

Investing Articles

2 FTSE 100 stocks I’d sell in June

| G A Chester

G A Chester explains why he believes the valuations of these two FTSE 100 (INDEXFTSE:UKX) stocks are far too high.

Read more »

Investing Articles

Why I think AstraZeneca is a must-buy dividend stock

| Kirsteen Mackay

A steadily climbing share price, varied product development and positive trial results point to continued success for this big pharma…

Read more »

Investing Articles

2 FTSE 100 world-beating income growth stocks I’d buy to hold forever

| Rupert Hargreaves

These FTSE 100 (INDEXFTSE:UKX) stocks have a track record of creating wealth for investors, that's why they're fantastic buy-and-hold investments…

Read more »

Investing Articles

Will the AstraZeneca share price be boosted by positive trial results?

| Stepan Lavrouk

AstraZeneca plc (LON: AZN) reports excellent data for cancer drug Lynparza. Can this help drive the share price upwards?

Read more »

Investing Articles

Top shares for June 2019

| The Motley Fool Staff

We asked our freelance writers to share their top stock picks for the month.

Read more »

Investing Articles

Is the AstraZeneca share price a FTSE 100 bargain?

| G A Chester

G A Chester discusses the investment case for FTSE 100 (INDEXFTSE:UKX) giant AstraZeneca plc (LON:AZN) and a small-cap pharma firm…

Read more »

Investing Articles

Will AstraZeneca’s new strategy make the share price soar?

| Stepan Lavrouk

A pivot to cancer treatment has been profitable for AstraZeneca plc (LON:AZN), but can it last?

Read more »